Trial Profile
Effect of food on low-dose, extended release, once daily formulation of AGB 101
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Nov 2015
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Mild cognitive impairment
- Focus Pharmacokinetics
- 16 Nov 2015 New trial record
- 06 Nov 2015 Results published in the Media Release